Protein redistribution in TCR-directed NF-kB activation
TCR 介导的 NF-kB 激活中的蛋白质重新分布
基本信息
- 批准号:7340398
- 负责人:
- 金额:$ 32.47万
- 依托单位:
- 依托单位国家:美国
- 项目类别:
- 财政年份:2006
- 资助国家:美国
- 起止时间:2006-02-01 至 2011-01-31
- 项目状态:已结题
- 来源:
- 关键词:AllyAntigen ReceptorsAntigensBasic ScienceBiochemicalCell divisionCellsCollectionComplexCoupledDataDevelopmentEvaluationEventFamilyFoundationsGene ExpressionGoalsImaging TechniquesIndividualLeadLifeLigationLocalizedLymphocyte antigenMediatingModificationMolecularMusNF-kappa BNumbersOutcomePathway interactionsPharmaceutical PreparationsPhosphorylationPlayProcessProteinsProteolysisReceptor ActivationRegulationRoleSignal PathwaySignal TransductionSignal Transduction PathwaySignaling ProteinT Cell Receptor Signaling PathwayT-Cell ActivationT-Cell ReceptorT-LymphocyteTestingTransducersWorkfunctional outcomesinsightnovelprotein distributionprotein protein interactionresearch studyresponsetranscription factor
项目摘要
Antigen-stimulated T cell division and acquisition of effector functions are dependent upon signal
transduction directed by the T cell receptor (TCR), and the consequent activation of a number of
transcription factors that effect changes in gene expression. Transcription factors of the NF-KB family are of
central importance in this process. The TCR-regulated NF-KB activation pathway will be investigated
through a combination of molecular, biochemical, and highly advanced imaging techniques. The goal is to
establish mechanistic relationships between 1) protein-protein interactions, 2) subcellular protein
organization and 3) biochemical modification of cytoplasmic signal transducers in the TCR-directed NF-KB
pathway. This goal will be accomplished via the execution of three specific aims:
Aim1. Todetermine the mechanistic significance of localizedprotein-protein associations of signaling
intermediates in TCR-directed activation of NF-KB. We will test the hypothesis that TCR-directed NF-KB
signaling involves the orchestrated assembly and disassembly of defined protein complexes into discrete
subcellular domains, with specific protein complexes playing a critical mechanistic role.
Aim 2. Toinvestigate, in individual cells, the mechanistic relationship between antigen signal
strength, assembly of signal transduction complexes, and successful activation of the TCR-directed NF-KB
signal transduction pathway. Experiments will be directed towards the evaluation of the hypothesis that
antigen signals through the TCR are converted into "binary" outcomes of either no activation or full activation
of effector functions. Furthermore, these functional outcomes are dependent on signal transduction decision
events made at the single-cell level.
Aim 3. To define the roles of phosphorylation and the MALT1 interaction domain in the TCR-
mediated degradation and activation ofBcHO. We will perform experiments to test the hypothesis that
activation and proteolytic destruction of BcHO are mechanistically coupled, and that both processes are
regulated by BcHO interaction with MALT1 and by PKC-dependent phosphorylation of BcHO.
These studies will help establish the basic research foundation that could lead to the development of
novel immuno-modulatory drugs, which would function via highly specfic inhibition of antigen-receptor
mediated activation of the NF-KB signaling cascade.
抗原刺激的T细胞分裂和效应子功能的获得依赖于信号传导。
由T细胞受体(TCR)指导的转导,以及随后的许多免疫调节因子的激活,
影响基因表达变化的转录因子。NF-κ B家族的转录因子是
在这个过程中至关重要。将研究TCR调节的NF-κ B活化途径
通过分子生物化学和高度先进的成像技术的结合。目标是
建立1)蛋白质-蛋白质相互作用,2)亚细胞蛋白质
组织和3)TCR指导的NF-κ B中细胞质信号转导物的生物化学修饰
通路这一目标将通过执行三个具体目标来实现:
目标1.确定信号传导的局部蛋白质-蛋白质关联的机制意义
TCR介导的NF-κ B活化的中间体。我们将检验TCR介导的NF-κ B
信号传导涉及到特定蛋白质复合物的有序组装和分解,
亚细胞结构域,与特定的蛋白质复合物发挥关键的机械作用。
目标二。在单个细胞中,研究抗原信号
信号转导复合物的强度、组装和TCR指导的NF-κ B的成功活化
信号转导途径实验的目的是为了评估以下假设,
通过TCR的抗原信号被转换成无活化或完全活化的“二元”结果
效应器功能。此外,这些功能结果取决于信号转导决策
在单细胞水平上发生的事件。
目标3。为了明确磷酸化和MALT 1相互作用结构域在TCR中的作用,
介导的BcHO降解和激活。我们将进行实验来检验这一假设,
BcHO的激活和蛋白水解破坏是机械耦合的,并且这两个过程都是
通过BcHO与MALT 1的相互作用以及BcHO的PKC依赖性磷酸化来调节。
这些研究将有助于建立基础研究基础,
通过高度特异性抑制抗原受体发挥作用的新型免疫调节药物
介导的NF-κ B信号级联的激活。
项目成果
期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
数据更新时间:{{ journalArticles.updateTime }}
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
Brian Schaefer其他文献
Brian Schaefer的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
{{ truncateString('Brian Schaefer', 18)}}的其他基金
Protein redistribution in TCR-directed NF-kB activation
TCR 介导的 NF-kB 激活中的蛋白质重新分布
- 批准号:
7868753 - 财政年份:2009
- 资助金额:
$ 32.47万 - 项目类别:
Protein redistribution in TCR-directed NF-kB activation
TCR 介导的 NF-kB 激活中的蛋白质重新分布
- 批准号:
7758850 - 财政年份:2006
- 资助金额:
$ 32.47万 - 项目类别:
Protein redistribution in TCR-directed NF-kB activation
TCR 介导的 NF-kB 激活中的蛋白质重新分布
- 批准号:
7173305 - 财政年份:2006
- 资助金额:
$ 32.47万 - 项目类别:
Protein redistribution in TCR-directed NF-kB activation
TCR 介导的 NF-kB 激活中的蛋白质重新分布
- 批准号:
7567565 - 财政年份:2006
- 资助金额:
$ 32.47万 - 项目类别:
Protein redistribution in TCR-directed NF-kB activation
TCR 介导的 NF-kB 激活中的蛋白质重新分布
- 批准号:
7103078 - 财政年份:2006
- 资助金额:
$ 32.47万 - 项目类别:
相似海外基金
Development of back bone vectors for chimeric antigen receptors against key molecules, CD47 and CD24, activating macrophages
开发针对关键分子 CD47 和 CD24 的嵌合抗原受体的骨干载体,激活巨噬细胞
- 批准号:
23K06728 - 财政年份:2023
- 资助金额:
$ 32.47万 - 项目类别:
Grant-in-Aid for Scientific Research (C)
CAREER: Engineering next-generation chimeric antigen receptors for cancer immunotherapy using phospho-proteomics
职业:利用磷酸蛋白质组学设计用于癌症免疫治疗的下一代嵌合抗原受体
- 批准号:
2145853 - 财政年份:2022
- 资助金额:
$ 32.47万 - 项目类别:
Continuing Grant
Construction of a drug discovery platform utilizing antigen receptors that regulate the quality of cancer immunity
利用调节癌症免疫质量的抗原受体构建药物发现平台
- 批准号:
22K06603 - 财政年份:2022
- 资助金额:
$ 32.47万 - 项目类别:
Grant-in-Aid for Scientific Research (C)
Engineering synthetic adhesion receptors to enhance the sensitivity of therapeutic chimeric antigen receptors
工程合成粘附受体以增强治疗性嵌合抗原受体的敏感性
- 批准号:
MR/W031353/1 - 财政年份:2022
- 资助金额:
$ 32.47万 - 项目类别:
Research Grant
Modeling based design of chimeric antigen receptors for Natural Killer cell-based immunotherapy
用于基于自然杀伤细胞的免疫治疗的嵌合抗原受体的基于建模的设计
- 批准号:
10701754 - 财政年份:2022
- 资助金额:
$ 32.47万 - 项目类别:
Modeling based design of chimeric antigen receptors for Natural Killer cell-based immunotherapy
用于基于自然杀伤细胞的免疫治疗的嵌合抗原受体的基于建模的设计
- 批准号:
10557760 - 财政年份:2022
- 资助金额:
$ 32.47万 - 项目类别:
Chimeric antigen receptors on regulatory T cells as a treatment strategy in auto-immune diseases.
调节性 T 细胞上的嵌合抗原受体作为自身免疫性疾病的治疗策略。
- 批准号:
437200 - 财政年份:2020
- 资助金额:
$ 32.47万 - 项目类别:
Studentship Programs
Molecualr imaging for development of chimeric antigen receptors (CARs) resistant to T cell exhaustion
用于开发抗 T 细胞耗竭的嵌合抗原受体 (CAR) 的分子成像
- 批准号:
20H03536 - 财政年份:2020
- 资助金额:
$ 32.47万 - 项目类别:
Grant-in-Aid for Scientific Research (B)
Therapeutic Anti-HIV Chimeric Antigen Receptors Via Stem Cell Delivery
通过干细胞递送治疗性抗 HIV 嵌合抗原受体
- 批准号:
10542442 - 财政年份:2020
- 资助金额:
$ 32.47万 - 项目类别:
Therapeutic Anti-HIV Chimeric Antigen Receptors Via Stem Cell Delivery
通过干细胞递送治疗性抗 HIV 嵌合抗原受体
- 批准号:
9922602 - 财政年份:2020
- 资助金额:
$ 32.47万 - 项目类别: